Clinical Trial Update: Stroke Prevention in Sickle Cell Anemia (STOP 1) [Phase 3]

View source ↗

Summary

STOP 1 is a Phase 3 trial evaluating regular transfusion to prevent stroke in children with sickle cell disease; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Stroke

Snippet

Sponsor: Augusta University | Conditions: Anemia, Sickle Cell, Cerebral Embolism and Thrombosis | Phase 3 | Status: COMPLETED